FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993395413> ?p ?o ?g. }

• W1993395413 endingPage "S90" @default.
• W1993395413 startingPage "S87" @default.
• W1993395413 abstract "During the past decade we have witnessed a number of changes in the field of non-Hodgkin lymphoma (NHL), including new entities added to the classification as well as a better understanding of the biology of diffuse large B-cell lymphoma (DLBCL). An understanding of the epigenetics of NHL is also contributing new agents for the management of this disorder. It has become increasingly clear that DLBCL is a biologically and clinically heterogeneous cell type. Two major categories are now recognized: germinal center B cell and activated B-cell (ABC) types. The former is associated with a good prognosis while the latter is known to have a more adverse outcome. With the use of routine immunohistochemical stains, these two types can be identified. The ABC type is known to be NFK-B dependent. NFK-B is a therapeutic target for bortezomib which is being investigated as treatment for this subtype of DLBCL. Several major changes in the classification will be discussed among which the most important are the recognition of so-called borderline entities. One of the two most common of these is the borderline DLBCL/Burkitt tumor (DLBCL/BL) which has features of both DLBCL and Burkitt's lymphoma. Many of the cases in this DLBCL/BL category contain a translocation of MYC as well as BCL2, so-called “double-hit lymphomas” which have a very aggressive clinical behavior. The second common borderline entity is the mediastinal grey zone NHL (MGZL) which has pathological features intermediate between primary mediastinal B-cell lymphoma and nodular sclerosing Hodgkin lymphoma (NSHL). Overlapping clinical features include young age, male predominance, and localized mediastinal presentation. Anecdotal reports suggest MGZL is relatively resistant to Hodgkin-based chemotherapy. Epigenetic therapy represents a new concept. Histone deacetylase inhibitors (HDACi)and DNA methyltransferase inhibitors constitute a promising new class of antineoplastic agents. They modify the expression of genes related to cancer development. In this review, we discuss the role of HDACi in lymphomagenesis as well as in treatment. To understand the benefits of HDACi in lymphoma treatment, we must appreciate the crucial interplay between BCL6, p53, and STAT3. The STAT3 oncogene is involved in the ABC type of DLBCL, an unfavorable and frequently therapy-refractory lymphoma. STAT3 can be effectively suppressed by several HDACi. We will summarize the results of recent trials with HDACi such as romidepsin, panobinostat and valproic acid that have shown significant preliminary activity in recurrent and refractory lymphomas. Their future role in front-line management remains to be determined." @default.
• W1993395413 created "2016-06-24" @default.
• W1993395413 creator A5060386553 @default.
• W1993395413 date "2011-06-01" @default.
• W1993395413 modified "2023-10-07" @default.
• W1993395413 title "Non-Hodgkin's Lymphoma: The Old and the New" @default.
• W1993395413 cites W1976564639 @default.
• W1993395413 cites W1988703453 @default.
• W1993395413 cites W2003600960 @default.
• W1993395413 cites W2058232002 @default.
• W1993395413 cites W2093688721 @default.
• W1993395413 cites W2097856894 @default.
• W1993395413 cites W2100589019 @default.
• W1993395413 cites W2103563361 @default.
• W1993395413 cites W2111500154 @default.
• W1993395413 cites W2117964879 @default.
• W1993395413 cites W2119680582 @default.
• W1993395413 cites W2156517973 @default.
• W1993395413 cites W2158267770 @default.
• W1993395413 cites W2165455805 @default.
• W1993395413 cites W2225528156 @default.
• W1993395413 cites W2565959427 @default.
• W1993395413 cites W266518141 @default.
• W1993395413 cites W4252081935 @default.
• W1993395413 doi "https://doi.org/10.1016/j.clml.2011.03.029" @default.
• W1993395413 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22035756" @default.
• W1993395413 hasPublicationYear "2011" @default.
• W1993395413 type Work @default.
• W1993395413 sameAs 1993395413 @default.
• W1993395413 citedByCount "15" @default.
• W1993395413 countsByYear W19933954132013 @default.
• W1993395413 countsByYear W19933954132014 @default.
• W1993395413 countsByYear W19933954132015 @default.
• W1993395413 countsByYear W19933954132016 @default.
• W1993395413 countsByYear W19933954132017 @default.
• W1993395413 countsByYear W19933954132018 @default.
• W1993395413 countsByYear W19933954132023 @default.
• W1993395413 crossrefType "journal-article" @default.
• W1993395413 hasAuthorship W1993395413A5060386553 @default.
• W1993395413 hasConcept C126322002 @default.
• W1993395413 hasConcept C142724271 @default.
• W1993395413 hasConcept C143998085 @default.
• W1993395413 hasConcept C159654299 @default.
• W1993395413 hasConcept C203014093 @default.
• W1993395413 hasConcept C2776364478 @default.
• W1993395413 hasConcept C2777478702 @default.
• W1993395413 hasConcept C2778453870 @default.
• W1993395413 hasConcept C2778559949 @default.
• W1993395413 hasConcept C2779338263 @default.
• W1993395413 hasConcept C502942594 @default.
• W1993395413 hasConcept C71924100 @default.
• W1993395413 hasConcept C96926380 @default.
• W1993395413 hasConceptScore W1993395413C126322002 @default.
• W1993395413 hasConceptScore W1993395413C142724271 @default.
• W1993395413 hasConceptScore W1993395413C143998085 @default.
• W1993395413 hasConceptScore W1993395413C159654299 @default.
• W1993395413 hasConceptScore W1993395413C203014093 @default.
• W1993395413 hasConceptScore W1993395413C2776364478 @default.
• W1993395413 hasConceptScore W1993395413C2777478702 @default.
• W1993395413 hasConceptScore W1993395413C2778453870 @default.
• W1993395413 hasConceptScore W1993395413C2778559949 @default.
• W1993395413 hasConceptScore W1993395413C2779338263 @default.
• W1993395413 hasConceptScore W1993395413C502942594 @default.
• W1993395413 hasConceptScore W1993395413C71924100 @default.
• W1993395413 hasConceptScore W1993395413C96926380 @default.
• W1993395413 hasLocation W19933954131 @default.
• W1993395413 hasLocation W19933954132 @default.
• W1993395413 hasOpenAccess W1993395413 @default.
• W1993395413 hasPrimaryLocation W19933954131 @default.
• W1993395413 hasRelatedWork W1614256433 @default.
• W1993395413 hasRelatedWork W2136877952 @default.
• W1993395413 hasRelatedWork W2144311569 @default.
• W1993395413 hasRelatedWork W2220838850 @default.
• W1993395413 hasRelatedWork W2582697615 @default.
• W1993395413 hasRelatedWork W2731187888 @default.
• W1993395413 hasRelatedWork W2806991430 @default.
• W1993395413 hasRelatedWork W2937775576 @default.
• W1993395413 hasRelatedWork W3010560328 @default.
• W1993395413 hasRelatedWork W4250397071 @default.
• W1993395413 hasVolume "11" @default.
• W1993395413 isParatext "false" @default.
• W1993395413 isRetracted "false" @default.
• W1993395413 magId "1993395413" @default.
• W1993395413 workType "article" @default.